The generic drug production industry focuses on producing medications that are similar but cheaper than brand-name counterparts, allowing for increased access to necessary health solutions. These companies manufacture various formulations, from tablets and capsules to injectables, targeting a wide array of medical conditions. As the healthcare landscape evolves, an emphasis on biosimilars and patent expirations creates opportunities for new entrants. Furthermore, increasing healthcare expenditure across emerging markets contributes to solid growth prospects in this industry, enhancing competition while striving to maintain quality and affordability for patients globally.

This list features 28 influential generic drug production companies, varying notably in size and operational scope. Companies like Apotex and Ems are headquartered in Canada and Brazil, respectively, with substantial employee counts and diverse product ranges. Established over several decades, these organizations offer vital medications that meet a spectrum of healthcare needs while exemplifying commitment to quality and accessibility. Each company contributes uniquely to the market, suggesting an array of opportunities for growth and innovation.

Continue reading to discover the top generic drug production companies.

Top 28 Generic Drug Production Companies

1. Apotex Inc.

• Website: apotex.com
• Ownership type: Private Equity
• Headquarters: Toronto, Ontario, Canada
• Employee distribution: Canada 68%, India 17%, Mexico 8%, Other 7%
• Latest funding: September 2022
• Founded year: 1974
• Headcount: 10001+
• LinkedIn: apotex-inc-

Apotex Inc. is a Canadian-based pharmaceutical company headquartered in Toronto, Ontario. Established in 1974, Apotex specializes in the production and distribution of generic medications, catering to healthcare providers, pharmacies, and patients. The company is dedicated to offering affordable alternatives to brand-name drugs, addressing various health conditions. Apotex operates on a global scale, with a portfolio of over 300 products available in more than 115 countries. The company emphasizes quality and accessibility in its operations, ensuring that its products meet stringent regulatory standards. With a workforce of over 6,000 employees, Apotex is committed to research and development, continuously innovating to expand its product offerings and improve patient care. The company has a significant presence in Canada, India, and Mexico, reflecting its strategic approach to global health.

2. Ems

• Website: ems.com.br
• Ownership type: Private
• Headquarters: Hortolândia, Sao Paulo, Brazil
• Employee distribution: Brazil 99%, Other 1%
• Latest funding: Other (Debt), $91.1M, August 2024
• Founded year: 1964
• Headcount: 1001-5000
• LinkedIn: ems

Ems, founded in 1964 and based in Hortolândia, São Paulo, Brazil, is a private pharmaceutical manufacturer that specializes in generic medications. With a workforce of over 12,000 employees, the company has a strong presence in the Brazilian market, where it ranks highly in terms of sales and units sold. Ems is committed to making healthcare more accessible by offering a wide range of affordable medication options. The company has also engaged in various initiatives to support healthcare providers and promote health awareness among consumers. Recently, Ems secured funding of approximately $91 million, which reflects its ongoing growth and investment in the pharmaceutical sector.

3. Intas Pharmaceuticals

• Website: intaspharma.com
• Ownership type: Private Equity
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 99%, Other 1%
• Latest funding: October 2022
• Founded year: 2000
• Headcount: 10001+
• LinkedIn: intas-biopharmaceuticals

Intas Pharmaceuticals Limited, founded in 2000 and based in Ahmedabad, Gujarat, India, is a pharmaceutical company that focuses on the development, manufacturing, and marketing of generic therapeutic drugs. With a workforce exceeding 17,000 employees, Intas operates primarily in India, with a small percentage of its workforce located internationally. The company has built a strong reputation for its commitment to quality and innovation, serving healthcare professionals and organizations across more than 85 countries. Intas has a comprehensive product portfolio that includes a wide range of formulations, from tablets to injectables and newer drugs. The company is also recognized for its investment in research and development, with over 550 scientists working in advanced facilities. Intas has received various global regulatory approvals, allowing it to compete effectively in major pharmaceutical markets. Its strategic focus on biosimilars and new chemical entities positions it well for future growth in the industry.

4. Joswe Medical

• Website: joswe.com
• Ownership type: Private
• Headquarters: Amman, Amman Governorate, Jordan
• Employee distribution: Jordan 76%, Iraq 10%, Saudi Arabia 8%, Other 6%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: joswe-medical

Joswe Medical, founded in 1996, is a pharmaceutical manufacturer located in Amman, Jordan. The company is dedicated to producing high-quality branded first generic medicines, aiming to improve access to essential medications across the MENA region. With a workforce of approximately 439 employees, Joswe Medical has developed a robust portfolio that includes over 160 pharmaceutical products spanning 14 therapeutic categories, such as CNS, cardiovascular, and anti-infective medications. The company is recognized for its innovative approach to pharmaceutical manufacturing, focusing on filling critical gaps in the market. Joswe Medical adheres to strict quality and compliance standards, ensuring that their products meet the requirements of various regulatory authorities. Their mission emphasizes the importance of making healthcare accessible and affordable, reflecting their commitment to addressing significant health challenges in the communities they serve.

5. Opsonin Pharma Ltd

• Website: opsonin-pharma.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 99%
• Founded year: 1956
• Headcount: 5001-10000
• LinkedIn: opsonin-pharma

Opsonin Pharma Ltd, based in Dhaka, Bangladesh, is a pharmaceutical company that develops, manufactures, and markets generic medicines for human use. Established in 1956, Opsonin has grown to become a significant player in the pharmaceutical sector, focusing on improving healthcare quality both locally and internationally. The company offers a wide array of pharmaceutical products, including over 350 brands and more than 800 SKUs, catering to various therapeutic classes such as antibiotics, antiulcerants, and antidiabetics. Opsonin is also involved in the agrovet sector, producing animal health products. The company has made substantial investments in modern manufacturing facilities that comply with international standards, including those set by the US-FDA and EU regulatory bodies. Opsonin's commitment to quality and affordability has earned it a respected position among healthcare providers and consumers alike. With a strong emphasis on export, Opsonin has successfully penetrated markets in Asia, Africa, and the Middle East, further solidifying its role in the global pharmaceutical landscape.

6. Alvogen

• Website: alvogen.com
• Ownership type: Corporate
• Headquarters: Montville, New Jersey, United States (USA)
• Latest funding: Other (Debt), $669.0M, March 2025
• Founded year: 2009
• Headcount: 1001-5000
• LinkedIn: alvogen

Alvogen is a privately owned pharmaceutical company based in Montville, New Jersey, established in 2009. The company specializes in the development, manufacturing, and marketing of generic medications, injectables, and over-the-counter products. Alvogen serves healthcare providers, pharmacies, and patients, with a mission to enhance access to high-quality medicines at affordable prices. The company operates a robust manufacturing facility in Norwich, New York, and has a portfolio that includes over 50 products targeting various therapeutic areas such as oncology, cardiology, and respiratory medicine. Alvogen is also involved in the production of complex generics and injectables, showcasing their capabilities in challenging pharmaceutical formulations. Their commitment to quality is underscored by a strong focus on research and development, which fuels their growing pipeline of products. Recently, Alvogen secured $669 million in funding, reflecting their strategic initiatives and potential for future growth in the pharmaceutical market.

7. Medochemie Ltd

• Website: medochemie.com
• Ownership type: Private
• Headquarters: Limassol, Limassol, Cyprus
• Employee distribution: Cyprus 46%, Greece 13%, Romania 6%, Other 35%
• Founded year: 1976
• Headcount: 1001-5000
• LinkedIn: medochemie-ltd

Medochemie Ltd, based in Limassol, Cyprus, is a pharmaceutical company founded in 1976 by Dr. Andreas Pittas. The company specializes in the development, manufacturing, and distribution of branded generic and patented medications. With a workforce of approximately 2,000 employees, Medochemie operates 15 manufacturing sites, including nine in Cyprus, one in the Netherlands, and five in Vietnam. The company has secured over 5,145 marketing authorizations for around 630 pharmaceutical products across more than 10 therapeutic categories. Medochemie is dedicated to quality, operating in compliance with European guidelines and WHO standards. They serve healthcare providers and organizations in 122 countries, emphasizing their mission to deliver quality drug treatments at affordable prices. Medochemie is also a founding member of Medicines for Europe, reflecting their active role in the pharmaceutical industry.

8. Pharco Corporation

• Website: pharco.org
• Ownership type: Private
• Headquarters: Alexandria, Scotland, United Kingdom (UK)
• Employee distribution: Egypt 95%, Saudi Arabia 3%, Other 2%
• Latest funding: IPO, May 2006
• Founded year: 1987
• Headcount: 5001-10000
• LinkedIn: pharco-corporation

Pharco Corporation, based in Alexandria, Egypt, is a prominent pharmaceutical manufacturer that specializes in the development, production, and marketing of a wide array of pharmaceutical products. Founded in 1987, Pharco has grown to become the largest manufacturer of pharmaceuticals in Egypt and a key player in the MENA region. The company focuses on generics and branded generics, with a particular emphasis on providing effective and affordable treatments for diseases such as Hepatitis C. Pharco operates through multiple subsidiaries, producing over 450 brands and exporting to more than 50 countries. The company is committed to research and development, ensuring that they remain at the forefront of pharmaceutical innovation. With a workforce of over 8,000 employees, Pharco is dedicated to delivering high-quality pharmaceutical products to healthcare providers and patients alike.

9. Synthon

• Website: synthon.com
• Ownership type: Private Equity
• Headquarters: Nijmegen, Gelderland, Netherlands
• Employee distribution: Spain 38%, Netherlands 23%, Chile 15%, Other 25%
• Latest funding: December 2024
• Founded year: 1991
• Headcount: 1001-5000
• LinkedIn: synthon

Synthon, founded in 1991 and based in Nijmegen, Netherlands, is a pharmaceutical company that specializes in the development, manufacturing, and commercialization of complex generic medicines. With a workforce of approximately 1,320 employees, the company operates globally, with significant operations in Spain, Chile, Argentina, the Czech Republic, and Mexico. Synthon's portfolio includes a wide range of high-quality generic products across various therapeutic areas, including oncology and central nervous system disorders. The company prides itself on its innovative approach to drug development, utilizing advanced technologies and rigorous scientific methodologies to ensure the safety and efficacy of its products. Synthon also maintains a vertically integrated manufacturing network, which enhances its reliability and quality assurance. The company is committed to improving patient access to affordable medications and actively seeks partnerships to expand its reach in the market.

10. Generis Farmacêutica

• Website: generis.pt
• Ownership type: Corporate
• Headquarters: Amadora, Lisbon, Portugal
• Employee distribution: Portugal 99%
• Latest funding: $142.9M, January 2017
• Founded year: 2006
• Headcount: 201-500
• LinkedIn: generis-farmaceutica-sa

Generis Farmacêutica, based in Amadora, Lisbon, Portugal, is a pharmaceutical company that specializes in the production and distribution of generic medications. Established in 2006, Generis has built a reputation for providing affordable healthcare solutions, primarily serving hospitals and pharmacies across Portugal. The company operates a state-of-the-art manufacturing facility, which has the capacity to produce up to 30 million packages of medication annually. This capability allows Generis to maintain a robust portfolio of generic drugs, making it one of the key partners for hospitals in the region. The company is dedicated to quality assurance and adheres to stringent manufacturing standards, ensuring that its products meet the healthcare sector's demands. Generis also engages in export activities, distributing its medications globally, which highlights its commitment to expanding access to essential medicines.

11. Globalpharma LLC

• Website: globalpharma.ae
• Ownership type: Corporate
• Headquarters: Dubai, Dubai, United Arab Emirates (UAE)
• Employee distribution: United Arab Emirates 78%, Saudi Arabia 17%, Other 4%
• Latest funding: $30.0M, September 2021
• Founded year: 1998
• Headcount: 201-500
• LinkedIn: global-pharma-llc

Globalpharma LLC, founded in 1998 and based in Dubai, UAE, is a pharmaceutical manufacturer that specializes in the production and distribution of generic medicines. The company operates two manufacturing plants that adhere to current Good Manufacturing Practice (cGMP) standards, ensuring that their products meet high-quality benchmarks. Globalpharma's product offerings include a wide range of medications, such as vitamins, anti-infectives, and pain relievers, catering to various health conditions. They have established a strong market presence in the GCC and select African countries, launching new products to meet the unmet needs of patients. Their flagship brands, including Gloclav® and Glomox®, are well-regarded in the region. Globalpharma is also committed to supporting healthcare professionals through continuous medical education initiatives, further solidifying their role in the healthcare ecosystem.

12. Hipolabor Farmacêutica Ltda

• Website: hipolabor.com.br
• Ownership type: Private
• Headquarters: Belo Horizonte, Minas Gerais, Brazil
• Employee distribution: Brazil 100%
• Founded year: 1984
• Headcount: 501-1000
• LinkedIn: hipolabor-farmaceutica-ltda

Hipolabor Farmacêutica Ltda, based in Belo Horizonte, Minas Gerais, Brazil, is a private pharmaceutical manufacturer that has been operational since 1984. The company focuses on the production and commercialization of generic injectable medications, catering to healthcare providers and institutions throughout Brazil. With a workforce of approximately 948 employees, Hipolabor operates modern manufacturing facilities, including a significant industrial park in Montes Claros, which is recognized as one of the most advanced in the country. The company emphasizes rigorous quality control processes and invests in technology and innovation to ensure the safety and efficacy of its products. Hipolabor's mission is to enhance public health by providing access to effective pharmaceuticals, thereby improving the quality of life for patients across Brazil.

13. Neopharma

• Website: neopharma.com
• Ownership type: Private
• Headquarters: Abu Dhabi, Abu Dhabi, United Arab Emirates (UAE)
• Employee distribution: United Arab Emirates 87%, Saudi Arabia 4%, Other 9%
• Founded year: 2003
• Headcount: 5001-10000
• LinkedIn: neopharmaglobal

Neopharma, established in 2003 and headquartered in Abu Dhabi, UAE, is a pharmaceutical manufacturer that specializes in producing high-quality medications, including both branded and generic formulations, as well as active pharmaceutical ingredients (APIs). The company operates a global manufacturing network with ten facilities across three continents, serving healthcare providers in over 50 countries. Neopharma is dedicated to delivering affordable and effective pharmaceutical solutions, with a strong focus on innovation and quality. Their product portfolio includes over 200 medications across various therapeutic categories, such as anti-infectives, cardiology, and oncology. Neopharma's commitment to research and development is evident in their efforts to create patent non-infringing processes and products, ensuring they meet the evolving needs of the healthcare market. The company has also formed strategic partnerships with notable pharmaceutical giants, enhancing its capabilities in the industry.

14. Ultra Laboratorios

• Website: ultralaboratorios.com.mx
• Ownership type: Private
• Headquarters: Guadalajara, Jalisco, Mexico
• Employee distribution: Mexico 100%
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: ultra-laboratorios-s-a--de-c-v-

Ultra Laboratorios S.A. de C.V. is a Mexican pharmaceutical company founded in 2001, located in Guadalajara, Jalisco. The company specializes in the development, manufacturing, and distribution of generic medicines, catering to healthcare professionals, pharmacies, and consumers. With a workforce of approximately 740 employees, Ultra Laboratorios has built a reputation for producing high-quality, safe, and effective pharmaceutical products. Their extensive catalog includes over 1,000 different products, primarily focusing on oral solid medicines. The company is recognized for its commitment to pharmaceutical ethics and continuous improvement, supported by a robust research and development department. Ultra Laboratorios operates under strict regulatory standards, ensuring compliance with the requirements set by COFEPRIS, the Mexican health authority. Their mission emphasizes enhancing health and well-being through accessible medication, positioning them as a key player in the Mexican pharmaceutical market.

15. Pharmascience

• Website: pharmascience.com
• Ownership type: Private
• Headquarters: Montreal, Quebec, Canada
• Employee distribution: Canada 93%, Other 7%
• Founded year: 1983
• Headcount: 1001-5000
• LinkedIn: pharmascience

Pharmascience, based in Montreal, Quebec, is a private pharmaceutical company that specializes in the production and marketing of generic medications. Established in 1983, the company has grown to employ approximately 1,845 individuals, primarily in Canada. Pharmascience is dedicated to making essential treatments accessible to healthcare providers, pharmacies, and patients. They manufacture a wide range of products, including prescription medications, over-the-counter drugs, and injectables, all produced within Canada. The company is recognized for its commitment to quality and community involvement, actively participating in various charitable initiatives. Pharmascience's products are distributed in more than 50 countries, showcasing its global outreach and impact in the pharmaceutical industry.

16. Zydus Pharmaceuticals (USA) Inc.

• Website: zydususa.com
• Ownership type: Private
• Headquarters: Pennington, New Jersey, United States (USA)
• Employee distribution: United States (USA) 56%, India 40%, Other 4%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: zydus-pharmaceuticals-usa-inc-

Zydus Pharmaceuticals (USA) Inc., based in Pennington, New Jersey, is a pharmaceutical company that focuses on the production and distribution of generic and branded medications. Founded in 2005, Zydus has grown to offer over 500 stock-keeping units (SKUs) in the U.S. market. The company is recognized for its commitment to providing high-quality, FDA-approved medications that cater to various therapeutic needs. Zydus operates under the umbrella of Zydus Lifesciences, a global healthcare provider with a significant footprint in multiple countries. The company has made strides in expanding its portfolio, particularly in complex generics, and has filed numerous drug master files and ANDAs with the FDA. Their facilities are equipped to handle a wide range of dosage forms, ensuring they meet the demands of healthcare providers and patients alike.

17. Sandoz Canada

• Website: sandoz.ca
• Ownership type: Corporate
• Headquarters: Boucherville, Quebec, Canada
• Employee distribution: Canada 100%
• Latest funding: May 2018
• Founded year: 1980
• Headcount: 201-500
• LinkedIn: sandozcanada

Sandoz Canada, established in 1980 and located in Boucherville, Quebec, is a corporate entity that specializes in the development and distribution of generic and biosimilar medicines. With a workforce of approximately 234 employees, Sandoz Canada plays a significant role in the pharmaceutical landscape by ensuring that healthcare professionals and patients have access to affordable medications. The company emphasizes innovation and quality in its product offerings, which include a wide range of generics and biosimilars. Sandoz Canada is dedicated to meeting the needs of the healthcare industry, and their commitment to corporate responsibility further underscores their relevance in the pharmaceutical sector. They also provide patient support programs, enhancing their engagement with the community and healthcare providers.

18. Medical Union Pharmaceuticals

• Website: mupeg.com
• Ownership type: Private
• Headquarters: Cairo, Cairo Governorate, Egypt
• Employee distribution: Egypt 97%, Other 3%
• Founded year: 1984
• Headcount: 1001-5000
• LinkedIn: medical-union-pharmaceuticals-mup

Medical Union Pharmaceuticals (MUP) is a private pharmaceutical manufacturer based in Cairo, Egypt, established in 1984. The company specializes in the development, manufacturing, and marketing of a wide array of branded and generic medications. MUP's operations are primarily focused on serving healthcare providers and patients across the Middle East, Africa, and Asia, with a strong emphasis on delivering high-quality and affordable medicines. The company boasts a portfolio of over 200 products, covering various therapeutic areas, and has a significant presence in the export market, reaching more than 40 countries. MUP operates four manufacturing facilities, producing millions of units annually, and is committed to maintaining high standards of quality through rigorous quality management systems. Their research and development efforts are geared towards creating innovative solutions to improve health outcomes, particularly for patients who cannot afford expensive medications.

19. betapharm Arzneimittel GmbH

• Website: betapharm.de
• Ownership type: Corporate
• Headquarters: Augsburg, Bavaria, Germany
• Employee distribution: Germany 100%
• Latest funding: $577.4M, March 2006
• Founded year: 1993
• Headcount: 10001+
• LinkedIn: betapharm-arzneimittel-gmbh

betapharm Arzneimittel GmbH, established in 1993 and located in Augsburg, Bavaria, is a pharmaceutical company focused on the production and distribution of generic medications. The company serves pharmacies and healthcare professionals, emphasizing the importance of affordable and quality pharmaceutical products. With a product range that includes over 150 active ingredients in more than 900 forms, betapharm addresses various medical needs, particularly in areas like cardiology, neurology, and pain management. Since becoming part of the international Dr. Reddy’s Laboratories group in 2006, betapharm has strengthened its position in the market, enhancing its ability to deliver accessible medication options. The company is dedicated to improving patient care and actively engages in initiatives that provide valuable information to patients regarding their health and rights.

20. Nabiqasim Group

• Website: nabiqasim.com
• Ownership type: Private
• Headquarters: Karachi, Sindh, Pakistan
• Employee distribution: Pakistan 98%, Other 2%
• Founded year: 1967
• Headcount: 1001-5000
• LinkedIn: nabiqasim-group

Nabiqasim Industries (Pvt.) Ltd., established in 1967 and based in Karachi, Pakistan, is a pharmaceutical manufacturer that specializes in branded generic formulations. The company is dedicated to providing high-quality, safe, and effective healthcare solutions across various medical fields, including cardiology, surgery, and neurology. With a workforce of approximately 1,429 employees, Nabiqasim operates a state-of-the-art cGMP-compliant manufacturing facility that spans 120,000 square feet. This facility is equipped with modern machinery and infrastructure, ensuring that all products meet international standards. The company has a strong commitment to quality, supported by independent quality control and assurance departments. Nabiqasim's products are exported to over 50 countries, highlighting its significant global presence in the pharmaceutical market. The company also engages in contract manufacturing, further expanding its operational capabilities.

21. KVK Tech, Inc.

• Website: kvktech.com
• Ownership type: Private
• Headquarters: Newtown, Pennsylvania, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2004
• Headcount: 501-1000
• LinkedIn: kvk-tech-inc-

KVK Tech, Inc., founded in 2004 and based in Newtown, Pennsylvania, is a pharmaceutical manufacturer that specializes in the development and production of FDA-approved generic and specialty brand medications. The company is dedicated to providing affordable alternatives to high-cost brand medicines, serving pharmacies, healthcare providers, and patients. KVK Tech operates its manufacturing facilities in the United States, adhering to strict FDA, DEA, and DEP guidelines to ensure quality and compliance. With a workforce of around 214 employees, KVK Tech emphasizes continuous improvement and innovation in its operations. The company is actively expanding its capabilities, including the construction of a new sterile injectable plant, which reflects its commitment to addressing unmet patient needs and enhancing its product portfolio. KVK Tech's mission is to deliver safe, effective, and affordable pharmaceuticals, ensuring that patients have access to high-quality medicines when they need them.

22. Healthcare Pharmaceuticals Limited

• Website: hplbd.com
• Ownership type: Private
• Headquarters: Dhaka, Dhaka, Bangladesh
• Employee distribution: Bangladesh 98%, Other 2%
• Founded year: 1996
• Headcount: 1001-5000
• LinkedIn: healthcare-pharmaceuticals-ltd

Healthcare Pharmaceuticals Limited (HPL) is a pharmaceutical manufacturer located in Dhaka, Bangladesh, founded in 1996. The company specializes in producing branded generic medicines, catering to healthcare providers, hospitals, and pharmacies. HPL's product range spans various therapeutic classes, including antibiotics, anti-diabetics, anti-cancer medications, and more. They offer over 570 branded products derived from 250 generics, showcasing their extensive involvement in the generic drug market. HPL emphasizes quality and innovation, with a robust research and development team dedicated to creating novel drug delivery systems and maintaining high manufacturing standards. Their facilities include solid and sterile units, as well as specialized oncology and hormone units, all designed to meet international quality standards. HPL is also engaged in contract manufacturing, providing services to other pharmaceutical companies. Their operations extend beyond Bangladesh, with a focus on expanding their global footprint.

23. Calox International C.A.

• Website: calox.com
• Ownership type: Private
• Headquarters: Caracas, Capital, Venezuela
• Employee distribution: Venezuela 77%, Costa Rica 11%, Nicaragua 3%, Other 8%
• Founded year: 1935
• Headcount: 201-500
• LinkedIn: calox-international-c.a.

Calox International C.A. is a pharmaceutical company based in Caracas, Venezuela, with a history dating back to 1935. The company specializes in the manufacturing and marketing of quality medications, particularly focusing on generic drugs. They serve a wide array of clients, including healthcare institutions, pharmacies, hospitals, and consumers, ensuring access to essential medications. Calox has a notable presence in Central America and the Caribbean, having expanded its operations to countries such as Costa Rica, Nicaragua, and Ecuador. The company is recognized as the top producer of generic medications in Costa Rica and the Dominican Republic. Their product portfolio includes a variety of therapeutic lines, showcasing their commitment to addressing health needs in the region. Calox continues to pursue growth opportunities, aiming to expand further into the Andean region, which indicates their ambition and relevance in the pharmaceutical industry.

24. Saiph

• Website: saiph-labo.com
• Ownership type: Private
• Headquarters: Mohammedia, Ben Arous Governorate, Tunisia
• Employee distribution: Tunisia 96%, Iraq 2%, Other 2%
• Founded year: 1992
• Headcount: 501-1000
• LinkedIn: saiph

Laboratoires SAIPH, founded in 1992 and located in Mohammedia, Tunisia, is a private pharmaceutical manufacturer that focuses on producing generic medications. The company specializes in a range of therapeutic areas, including cardiovascular drugs and antibiotics, catering to healthcare providers, hospitals, and pharmacies. Saiph operates five manufacturing facilities that produce various forms of medications, including sterile forms, cephalosporins, penicillins, and soft gelatin capsules. The company has shown a strong commitment to quality and innovation, aiming to enhance access to essential medications in Tunisia and expand its reach across the African continent. Saiph has also engaged in partnerships with educational institutions to improve training in the pharmaceutical industry, reflecting its dedication to the sector's growth and development.

25. Laboratoires Galpharma

• Website: galpharma.tn
• Ownership type: Private
• Headquarters: Sfax, Sfax Governorate, Tunisia
• Employee distribution: Tunisia 100%
• Founded year: 1995
• Headcount: 201-500
• LinkedIn: galpharma

Laboratoires Galpharma is a pharmaceutical manufacturer located in Sfax, Tunisia, founded in 1995. The company specializes in the production of generic medications for human use, aiming to provide quality treatments to pharmacies and healthcare providers across Tunisia. With a workforce of approximately 221 employees, Galpharma has established itself as a key player in the local pharmaceutical industry. The company emphasizes the importance of quality, safety, and efficacy in its products, which span a wide range of therapeutic classes. Galpharma's manufacturing facilities are equipped with modern European technology, ensuring compliance with high standards of production and control. The company is committed to continuous improvement and innovation, striving to meet the growing healthcare needs of the Tunisian population.

26. Dexcel Pharma

• Website: dexcel.com
• Ownership type: Private
• Headquarters: Or Akiva, Haifa, Israel
• Employee distribution: Israel 90%, United Kingdom (UK) 6%, Germany 4%
• Founded year: 1968
• Headcount: 501-1000
• LinkedIn: dexcel-pharma

Dexcel Pharma, founded in 1968 and based in Or Akiva, Israel, is a private pharmaceutical company that focuses on the development, manufacturing, and commercialization of both innovative and generic drugs. With a workforce of approximately 512 employees, Dexcel operates globally, serving healthcare providers and patients with a wide range of pharmaceutical products. The company is particularly noted for its extensive portfolio of generic drugs, which includes established medications as well as niche and first-to-market offerings across various dosage forms. Dexcel maintains high-quality manufacturing standards, with facilities that are compliant with cGMP regulations and approved by major regulatory bodies such as the FDA and EMA. The company has invested significantly in research and development, demonstrating a commitment to innovation in drug formulation and delivery. Dexcel's operations extend beyond Israel, with a presence in key markets including the United States, Germany, and the United Kingdom, allowing them to effectively meet local market needs and opportunities.

27. Unipharm Ltd. Israel

• Website: unipharm.global
• Ownership type: Family Owned
• Headquarters: Tel Aviv-Yafo, Tel Aviv, Israel
• Employee distribution: Israel 100%
• Founded year: 1975
• Headcount: 201-500
• LinkedIn: unipharmil

Unipharm Ltd. Israel, established in 1975, is a family-owned pharmaceutical company based in Tel Aviv-Yafo. With a workforce of around 201-500 employees, Unipharm specializes in the research, development, and production of generic medications. The company has carved out a significant position in the Israeli pharmaceutical market, often being the first to introduce generic products. Their manufacturing facility, which opened in 2017, is EU-GMP certified, reflecting their commitment to high-quality production standards. Unipharm's product offerings cover a wide array of therapeutic areas, including cardiovascular health, central nervous system disorders, anti-infectives, and more. They actively engage in out-licensing agreements, providing regulatory support to partners looking to market their generics internationally. Unipharm's involvement in shaping intellectual property laws in Israel has also facilitated their success in launching generics, making them a notable player in the industry.

28. ratiopharm

• Website: ratiopharm.de
• Ownership type: Corporate
• Headquarters: Ulm, Baden-Württemberg, Germany
• Employee distribution: Germany 58%, Austria 22%, Spain 13%, Other 6%
• Latest funding: $4.0B, March 2010
• Founded year: 1973
• Headcount: 1001-5000
• LinkedIn: ratiopharm

ratiopharm GmbH, based in Ulm, Baden-Württemberg, Germany, is a pharmaceutical company that has been operational since 1973. The company specializes in the production and distribution of generic and over-the-counter medications, catering to pharmacies and consumers alike. With a workforce of approximately 581 employees, ratiopharm is committed to providing affordable health solutions across a wide array of products. Their portfolio includes around 2,500 medications that address various health needs, ensuring that they meet the demands of the market. As a subsidiary of the Teva Group, ratiopharm benefits from access to advanced research and technology, allowing them to maintain a competitive edge in the generic drug sector. Their focus on quality, sustainability, and social responsibility further underscores their commitment to the pharmaceutical industry.

Generic Drug Production Insights: Key Companies

Want to Find More Generic Drug Production Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!